MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2021

    Safinamide Improves Mood in Parkinson´s Disease. Results from the SAFINONMOTOR Study.

    C. Labandeira, MG. Alonso Losada, R. Yáñez Baña, I. Cimas Hernando, I. Cabo López, JM. Paz González, MJ. González Palmás, C. Martínez Miró, D. Santos García (Vigo, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on mood in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Evidence of Overlapping Pathology between Depression and Autonomic Dysfunction in Parkinson’s Disease

    M. Sklerov, E. Dayan, N. Browner, D. Rubinow, F. Frohlich (Chapel Hill, USA)

    Objective: To investigate the association between symptoms of depression and symptoms of autonomic dysfunction (AuD) in people with Parkinson’s disease (PD). Background: Depression and AuD…
  • MDS Virtual Congress 2020

    Cognitive function and depressive symptoms among older adults with serious difficulty walking in Americans

    Y. Zhang, Y. Qu, Q. Niu (Xi’an, China)

    Objective: The objective of this study was to ascertain level of cognitive function and its relationship with depression in American older adults with serious difficulty…
  • MDS Virtual Congress 2020

    CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: The aims of the present study were to investigate the levels of inflammatory cytokines in the cerebrospinal fluid (CSF) of drug-naïve Parkinson's Disease (PD)…
  • MDS Virtual Congress 2020

    Non-pharmacological Treatment for Parkinson’s Disease Patients with Depression: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment

    J.N Chen, P.K He, Y.H Zhang, YY. Gao, Y.H Qiu, Y. Li, Q.X Zhang, L.M Wang, J.H Zhao, K. Nie, L.J Wang (Guangzhou, China)

    Objective: This meta-analysis aims to assess the effect of non-pharmacological treatments for depression in patients with PD. Background: Antidepressants are the mainstay of treatment for…
  • MDS Virtual Congress 2020

    Non-Motor Symptoms In Chinese Patients With Isolated Generalized Dystonia: A Case-Control Study

    S.L Li, X.H Wan, L. Wang, YY. Mai, L. Qiao, DD. Zhang (Beijing, China)

    Objective: To explore non-motor symtoms in Chinese patients with isolated generalized dystonia. Background: Previous studies have indicated that non-motor symptoms are primary problems in focal…
  • MDS Virtual Congress 2020

    Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

    C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)

    Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…
  • MDS Virtual Congress 2020

    Effect of the MAO-B inhibitor and glutamate modulator safinamide on depressive symptoms in three Parkinson’s disease patients

    W.E Hofmann (Aschaffenburg, Germany)

    Objective: Patients suffering from Parkinson’s disease experience various motor and non-motor symptoms. Within the range of non-motor symptoms depression is reported as high as in…
  • MDS Virtual Congress 2020

    Endophenotyping adult-onset isolated cervical dystonia: Does period of onset of mood disorder matter?

    I. Ndukwe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: We aim to characterize clinical and demographic features pertaining to the time of onset of mood disorder in CD patients. Background: Mood disorder frequently…
  • MDS Virtual Congress 2020

    Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors

    D. Santos, T. de Deus, E. Suárez, L. Vela, M. Catalán, M. Álvarez Sauco, I. Gastón, M. Avila, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Seijo, C. Valero, J. González, S. Jesús, Ll. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, I. González Aramburu, V. Nogueira, C. Borrué, B. Solano, S. Escalante, E. Cubo, F. Carrillo, J. Kulisevsky, L. López Manzanares, M. Kurtis, M. Kurtis, P. Mir, P. Martínez Martín (A Coruña, Spain)

    Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both. Background: Depression and ICBs are…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley